Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-27

FDA Approved: VIGABATRIN — Original Application (Par Health USA, LLC)

View source ↗

Summary

FDA approves Vigabatrin original Abbreviated New Drug Application for Par Health USA, LLC (generic entry).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigabatrin (Vigabatrin)

Snippet

ORIG AP for VIGABATRIN (VIGABATRIN)